Do pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR { gamma }?
Pio attenuates Ang II-induced atherosclerosis via the interaction with SMC-specific PPARγ, but has no effect on the development of AAAs.
HCV screening in OST settings increases detection of HCV infection among people who inject drugs.